After 30 years of listing, employees have something to say.
Release time:
2023-06-12
Fang Yanfei (Shuangxi Pharmacy, Peak Pharmacy):
I joined Peak in 1993, which happened to be the year when Peak Stock went public. Shortly after entering the unit, the spike stock went public. At that time, stocks were a new term, a new thing. After work, almost all of everyone's topics are related to stocks. Colleagues organized groups to go to the stock exchange to find out the market and buy and sell stocks, and the economy has made a qualitative leap. In the remote factory areas of that era, almost all the gold necklaces with each hand were only basic configurations. The male workers in the cement factory were very good at finding objects. It was a scene of great enthusiasm. Looking back on the grand occasion at that time, it seems that I still remember it vividly.
Time flies, and inadvertently I have been working at the peak for 30 years. During the period, across a number of positions in cement and pharmaceutical industry, warehouse keeper, financial accounting, statistician, salesman, drug salesman, etc., the company created opportunities for me to learn and exercise, and provided a stage to show value. The conscientious work has also been affirmed by the company, won the honors of "excellent Communist Youth League member", "excellent female worker" and "excellent salesman", and led the team to obtain "advanced collective", and gained confidence in growth in life experience.
This year marks the 30th anniversary of the listing of the group company. The fruitful results of continuous development and growth are very gratifying. This year I also retired with honor. I am honored that my length of service is "the same age" as the company's listing. It is a great honor to grow together with the company for 30 years. On the occasion of the 30th anniversary of the listing of the group company, I sincerely wish the company to embark on a new journey, create new brilliance, and move towards a more brilliant future!
Wang Qinghong (Storage Department of Pharmaceutical Company):
I have been in the pharmaceutical company since 1991, and now it has been 32 years. Perhaps I was not born to do business. I was left in the warehouse because I was "stupid" and was not afraid of being dirty or tired. In addition, I was also a good hand at stacking piles. Due to the lack of technology and expertise, I cherish this hard-won job opportunity, strive to make no mistakes in the work, deliver goods quickly and accurately, review carefully and completely, and work hard in the details. Once problems are found, solve them in time.
As an ordinary member of the front line, looking at my work experience over the years, I feel that I need to be enthusiastic, patient and sincere. Take everything seriously, have a correct attitude and give priority to efficiency. Put your enthusiasm into unlimited work.
in the work of learning, work in learning, everything must follow the objective law. In my future work, I will take the peak spirit of "unity and struggle, truth-seeking and innovation, determination to rise to the top and climb the peak forever" as my action guide, and do my part in a down-to-earth manner.
This year is the 30th anniversary of the listing of Peak Stock. As a peak person, I expect her to be more perfect and wish her more brilliant. 19
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page